1. Home
  2. ASPN vs EVO Comparison

ASPN vs EVO Comparison

Compare ASPN & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASPN
  • EVO
  • Stock Information
  • Founded
  • ASPN 2001
  • EVO 1993
  • Country
  • ASPN United States
  • EVO Germany
  • Employees
  • ASPN N/A
  • EVO N/A
  • Industry
  • ASPN RETAIL: Building Materials
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • ASPN Consumer Discretionary
  • EVO Health Care
  • Exchange
  • ASPN Nasdaq
  • EVO Nasdaq
  • Market Cap
  • ASPN 486.5M
  • EVO 1.5B
  • IPO Year
  • ASPN 2014
  • EVO 2021
  • Fundamental
  • Price
  • ASPN $6.40
  • EVO $4.08
  • Analyst Decision
  • ASPN Strong Buy
  • EVO Buy
  • Analyst Count
  • ASPN 10
  • EVO 2
  • Target Price
  • ASPN $21.78
  • EVO $5.90
  • AVG Volume (30 Days)
  • ASPN 1.4M
  • EVO 117.0K
  • Earning Date
  • ASPN 08-06-2025
  • EVO 08-13-2025
  • Dividend Yield
  • ASPN N/A
  • EVO N/A
  • EPS Growth
  • ASPN N/A
  • EVO N/A
  • EPS
  • ASPN N/A
  • EVO N/A
  • Revenue
  • ASPN $436,921,000.00
  • EVO $851,944,444.00
  • Revenue This Year
  • ASPN N/A
  • EVO $10.08
  • Revenue Next Year
  • ASPN $24.31
  • EVO $10.99
  • P/E Ratio
  • ASPN N/A
  • EVO N/A
  • Revenue Growth
  • ASPN 51.90
  • EVO 1.50
  • 52 Week Low
  • ASPN $4.16
  • EVO $2.84
  • 52 Week High
  • ASPN $33.15
  • EVO $5.64
  • Technical
  • Relative Strength Index (RSI)
  • ASPN 57.67
  • EVO 57.98
  • Support Level
  • ASPN $5.75
  • EVO $4.15
  • Resistance Level
  • ASPN $6.21
  • EVO $4.35
  • Average True Range (ATR)
  • ASPN 0.32
  • EVO 0.11
  • MACD
  • ASPN 0.03
  • EVO 0.03
  • Stochastic Oscillator
  • ASPN 86.93
  • EVO 98.39

About ASPN Aspen Aerogels Inc.

Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Energy Industrial segment and the United States market. Some of its products include Pyrogel XTE; Cryogel Z; Spaceloft Subsea; and others.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: